Impact of Older Age in Patients Receiving Atezolizumab and Bevacizumab for Hepatocellular Carcinoma

ECU Author/Contributor (non-ECU co-authors, if there are any, appear on document)
et al (Creator)
Suneetha Amar (Creator)
Mahvish Muzaffar (Creator)
Abdul Rafeh Naqash (Creator)
Mathew Vithayathil (Creator)
Institution
East Carolina University (ECU )
Web Site: http://www.ecu.edu/lib/

Additional Information

Publication
Other
Language: English
Date: 2023
Subjects
anti-programmed death-ligand;anti-vascular endothelial growth factor;immunotherapy

Email this document to

This item references:

TitleLocation & LinkType of Relationship
Impact of Older Age in Patients Receiving Atezolizumab and Bevacizumab for Hepatocellular Carcinomahttp://hdl.handle.net/10342/12345The described resource references, cites, or otherwise points to the related resource.